2004
DOI: 10.1111/j.1468-1331.2004.00856.x
|View full text |Cite
|
Sign up to set email alerts
|

Guidelines for the diagnosis and management of neurological complications of HIV infection

Abstract: The spectrum of neurological complications of HIV‐infection has remained unchanged through the years, but its epidemiology changed remarkably as a result of the introduction of highly active antiretroviral therapy (HAART). Guidelines for the diagnosis and treatment of cerebral toxoplasmosis, cryptococcal meningitis, progressive multifocal leukoencephalopathy, CMV encephalitis, CMV polyradiculomyelitis, tuberculous meningitis, primary CNS lymphoma, HIV dementia, HIV myelopathy and HIV polyneuropathy are given w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
76
0
5

Year Published

2005
2005
2013
2013

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 103 publications
(81 citation statements)
references
References 60 publications
(43 reference statements)
0
76
0
5
Order By: Relevance
“…Highly active antiretroviral therapy (HAART) has failed to eliminate this aspect of HIV-1-associated disease, and in fact the prevalence of HIV dementia has increased in the post-HAART era, possibly because of HAART's positive effects on overall patient survival time [23][24][25]. It has further been suggested that HAART may be altering the presentation and/or pathogenesis of HIV dementia, resulting in a more slowly progressive, chronic form of the disease [23][24][25]. These observations highlight the need for new, adjunct therapeutic approaches aimed specifically at ameliorating or preventing HIV dementia.…”
Section: Introductionmentioning
confidence: 99%
“…Highly active antiretroviral therapy (HAART) has failed to eliminate this aspect of HIV-1-associated disease, and in fact the prevalence of HIV dementia has increased in the post-HAART era, possibly because of HAART's positive effects on overall patient survival time [23][24][25]. It has further been suggested that HAART may be altering the presentation and/or pathogenesis of HIV dementia, resulting in a more slowly progressive, chronic form of the disease [23][24][25]. These observations highlight the need for new, adjunct therapeutic approaches aimed specifically at ameliorating or preventing HIV dementia.…”
Section: Introductionmentioning
confidence: 99%
“…In this setting, minimally invasive diagnosis using CSF-PCR for CMV DNA is particularly useful. This tool showed 62-100% sensitivity and 89-100% of specificity in CMV encephalitis and polyradiculopathy 29 , and present positive and negative predictive values ranged between 86-95% and 95-98%, respectively [7][8][9] .…”
Section: Discussionmentioning
confidence: 99%
“…Treatment recommendations to neurologic CMV complications are diverse, but most suggest ganciclovir, foscarnet or both agents in combination 9,13,14,17,19,27,29,34 and highlight that initiating therapy promptly is critical for an optimal clinical response. Some authors recommend combination therapy in all cases 11,20 or in patients who have received prior antiviral therapy for CMV or in patients with disease progression under monotherapy 22,34 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…tório que envolve as estruturas situadas no espaço subaracnóideo da base do crânio, podendo promover bloqueio da circulação do líquido cefalorraqueano (LCR), determinando aumento da pre s s ã o intracraniana e alterações no exame do LCR 5 . No presente estudo, os relatamos um caso meningite tuberculosa que evoluiu com bloqueio do fluxo do LCR.…”
Section: Um Terço Da População Mundial Está Infectada C O M O M Y C Ounclassified